Expert Rev Anti Infect Ther. 2011;9(3):283-284. Pediatric patients are not simply 'little adults'. This mantra can be echoed throughout the entire discipline of pediatric medicine, where differences ...

Please provide your email address to receive an email when new articles are posted on . Researchers confirmed the dosing of a formulation including dolutegravir, abacavir and lamivudine in children ...

Acute necrotizing encephalopathy (ANE) is a rare but life-threatening pediatric neurologic disorder characterized by rapid progression and high mortality. Tocilizumab, an interleukin-6 receptor ...

Riding in the back of an ambulance managing a very sick child is far from the ideal time for a paramedic to do math. But often paramedics must do a few calculations in their heads to determine the ...

A comprehensive review found no evidence to support the changes made by the CDC to the recommendations for hepatitis B vaccination in children.

Duke Medicine is part of a groundbreaking initiative to reduce the risk and dangers faced everyday by millions of children who are prescribed medications that lack definitive data about pediatric ...

Larimar Therapeutics has initiated dosing for adolescents aged 12-17 in its pediatric pharmacokinetic (PK) run-in study for nomlabofusp, a potential treatment for Friedreich’s ataxia. Adolescents who ...

Vendor-supplied dosing eRules are not optimal for pediatric patients, according to a study in the Journal of the American Medical Information Association. Researchers studied seven months of ...

The establishment of a dedicated pediatric imaging department with dedicated pediatric computed tomography technologists for pediatric CT scans may lead to significant radiation dose reduction to the ...

Hepatitis B vaccination at birth is safe and effective compared with a delayed first dose, according to research published online Feb. 5 in Pediatrics.

Augmentin (amoxicillin/clavulanate potassium) is a brand-name drug prescribed for specific bacterial infections in adults and children. Augmentin comes as an oral ...

NORTH CHICAGO, Ill., Feb. 24, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved HUMIRA® (adalimumab) for the treatment of moderately to ...